Mark Rapoport

1.2k citations
8 papers · 973 indexed · 1 hit paper · h-index 8
Topics
Ocular Oncology and Treatments (4 papers)Alzheimer's disease research and treatments (2 papers)Bone Tumor Diagnosis and Treatments (2 papers)
Partner nations
United States

In The Last Decade

Mark Rapoport

8 papers receiving 952 citations

Hit Papers

Tau is essential to β-amyloid-induced neurotoxicity20022026201020182002200400600

Peers

Mark Rapoport
Comparison fields: 5 of 75
  • Physiology 657
  • Molecular Biology 349
  • Cellular and Molecular Neuroscience 340
  • Pharmacology 212
  • Cell Biology 142
Replace Pilar Gómez‐Ramos with:
Pilar Gómez‐Ramos Spain
Sean M. Riordan United States
Eiríkur Benedikz Sweden
Georges Lévesque Canada
Jianting Miao China
Hai-Yan Wu United States
Marina V. Yasvoina United Kingdom
Jason J. Fritz United States
Owen M. Peters United Kingdom
Kenichi Nagata Japan
Mark Rapoport relative to Pilar Gómez‐Ramos Spain Pilar Gómez‐Ramos's profile →
Citations per field
00.5×1.5×
Pilar Gómez‐Ramos · 1×
Citations per year

Countries citing papers authored by Mark Rapoport

Since Specialization
Citations

This map shows the geographic impact of Mark Rapoport's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Rapoport with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Rapoport more than expected).

Fields of papers citing papers by Mark Rapoport

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Rapoport. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Rapoport. The network helps show where Mark Rapoport may publish in the future.

Co-authorship network of co-authors of Mark Rapoport

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Rapoport. A scholar is included among the top collaborators of Mark Rapoport based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Rapoport. Mark Rapoport is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 16
2 11
3 24
4 28
5 29
6
Tau is essential to β-amyloid-induced neurotoxicitybreakdown →
651
7 119
8 95

About Mark Rapoport

Mark Rapoport is a scholar working on Ophthalmology, Rheumatology and Neurology, having authored 8 papers that have together received 973 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (4 papers), Alzheimer's disease research and treatments (2 papers) and Bone Tumor Diagnosis and Treatments (2 papers). The work is most often cited by research in Physiology (657 citations), Cellular and Molecular Neuroscience (340 citations) and Neurology (136 citations). Mark Rapoport has collaborated with scholars based in United States. Frequent co-authors include Adriana Ferreira, Hana N. Dawson, Lester I. Binder, Michael P. Vitek, Mahmood F. Mafee, Paul Greengard, Jian Feng, Hung‐Teh Kao, Sameer A. Ansari and Afshin Karimi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Journal of Neurochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026